Pharmacological Aids for Interactive Smoking Cessation
NRT_2
2 other identifiers
interventional
500
0 countries
N/A
Brief Summary
There is an important need for effective smoking cessation programs that both (a) promote the effective use of pharmacological aids, such as nicotine replacement products and bupropion, and (b) provide cognitive-behavioral support for stopping smoking.The Internet is an increasingly attractive intervention medium for delivering behavior change interventions, including smoking cessation.This study examined smoking cessation rates among adults participating in a randomized controlled trial of the Smokefree Partners: 21 Days to Freedom ™ program, a theoretically based, online smoking cessation program that included message tailoring and interactivity combined with the live personal support of a smoking cessation coach. Coaching support was provided almost entirely asynchronously via prescripted but individually tailored emails.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2001
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 29, 2014
CompletedFirst Posted
Study publicly available on registry
December 31, 2014
CompletedJanuary 1, 2015
December 1, 2014
3.9 years
December 29, 2014
December 31, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Smoking cessation
Current smoking status was determined with two items: (a) a stage of change measure indicating smoking status and (b) a measure indicating the number of cigarettes smoked in the past 7 days. Abstinence at 30-day posttest and 120-day follow-up was confirmed by the participant choosing both (a) the response of "I do not currently smoke; I quit in the last 6 months" to the stage of change measure and (b) a response of "0" to the question "During the past 7 days, how many cigarettes did you smoke each day?"
120 days
Secondary Outcomes (4)
Intentions to quit smoking
30 days and 120 days after baseline
intentions to quit and remain smokefree
30 days and 120 days after baseline
self-efficacy for quitting
30 days and 120 days after baseline
intentions to use a pharmacological smoking cessation aid (PA)
30 days and 120 days after baseline
Study Arms (2)
Smokefree Partners: 21 Days to Freedom
EXPERIMENTALSmoking cessation website program with live personal coach
Wait-list control
OTHER120-day wait-list and then provided access to the smoking cessation website
Interventions
Treatment subjects, who chose a quit date, were given 21 sessions to be viewed one session (i..e, one day) at a time, and an in-person smoking cessation coach to support them through their quit process via tailored email or phone coaching messages. Treatment users were encouraged to use pharmacological aids in their quit attempt, but smoking cessation aids were not provided.
Subjects randomized to the control condition were placed on a wait-list and given access to the smoking cessation program after 120 days and completion of the 120-day follow-up assessment.
Eligibility Criteria
You may qualify if:
- large worksites with internet connection
- thinking of quitting smoking
- years of age or older
You may not qualify if:
- not thinking of quitting smoking
- years of age or younger
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Susan Schroeder, MPH, MCHES
Oregon Center for Applied Science
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Scientist
Study Record Dates
First Submitted
December 29, 2014
First Posted
December 31, 2014
Study Start
February 1, 2001
Primary Completion
January 1, 2005
Study Completion
January 1, 2006
Last Updated
January 1, 2015
Record last verified: 2014-12